GlobeNewswire Inc | Nov 3, 2020 05:31PM EST

November 03, 2020

MARIETTA, Ga., Nov. 03, 2020 (GLOBE NEWSWIRE) -- MiMedx Group, Inc. (OTC PINK: MDXG) (MiMedx or the Company), an industry leader in advanced wound care and a therapeutic biologics company, today confirmed that the Companys common stock will commence trading on The Nasdaq Stock Market at the opening of trading on Wednesday, November 4, 2020, under the ticker symbol MDXG.

About MiMedx

MiMedx is an industry leader in advanced wound care and a therapeutic biologics company developing and distributing human placental tissue allografts with patent-protected processes for multiple sectors of healthcare. The Company processes the human placental tissue utilizing its proprietary PURION process methodology, among other processes, to produce allografts by employing aseptic processing techniques in addition to terminal sterilization. MiMedx has supplied over two million allografts, through both direct and consignment shipments. For additional information, please visit www.mimedx.com.

Contact

Hilary DixonInvestor Relations & Corporate Communications770.651.9066investorrelations@mimedx.com